| 1 | Study | 1.67% | |
| 2 | Cancer | 1.67% | |
| 3 | New | 0.79% | |
| 4 | Patients | 0.71% | |
| 5 | Risk | 0.69% | |
| 6 | Health | 0.63% | |
| 7 | Report | 0.6% | |
| 8 | Case | 0.55% | |
| 9 | Blood | 0.47% | |
| 10 | Disease | 0.47% | |
| 11 | Brain | 0.47% | |
| 12 | May | 0.44% | |
| 13 | ASCO | 0.44% | |
| 14 | Therapy | 0.41% | |
| 15 | HIV | 0.38% | |
| 16 | Prostate | 0.38% | |
| 17 | Linked | 0.36% | |
| 18 | AI | 0.36% | |
| 19 | Treatment | 0.33% | |
| 20 | Phase | 0.3% | |
| 21 | US | 0.3% | |
| 22 | Breast | 0.3% | |
| 23 | Heart | 0.3% | |
| 24 | Cell | 0.27% | |
| 25 | Care | 0.27% | |
| 26 | China | 0.27% | |
| 27 | Survival | 0.27% | |
| 28 | Researchers | 0.25% | |
| 29 | Dementia | 0.25% | |
| 30 | Effects | 0.25% | |
| 31 | Use | 0.25% | |
| 32 | Alzheimer’s | 0.25% | |
| 33 | Drug | 0.25% | |
| 34 | Vaccine | 0.25% | |
| 35 | Pain | 0.22% | |
| 36 | Exercise | 0.22% | |
| 37 | Found | 0.22% | |
| 38 | Research | 0.22% | |
| 39 | South | 0.22% | |
| 40 | Association | 0.22% | |
| 41 | Finds | 0.22% | |
| 42 | Help | 0.19% | |
| 43 | Early | 0.19% | |
| 44 | Lower | 0.19% | |
| 45 | First | 0.19% | |
| 46 | Chronic | 0.19% | |
| 47 | Surgery | 0.19% | |
| 48 | Patient | 0.19% | |
| 49 | Growth | 0.19% | |
| 50 | Women | 0.19% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||
Neoadjuvant Nivolumab Plus Chemo Significantly Improves OS Vs Chemo in Resectable NSCLC
OncLive
2025-06-03 23:39:50
“Phenomenal” Results with Perioperative Immunotherapy in NSCLC
Oncology News Central
2025-06-03 21:03:55